← ANALYSTS · TIPRANKS
Richard Law CFA · Goldman Sachs
Hits
50%
33 of 66 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+9.1%
Over a year after the rating, TipRanks’ measure
Our companies rated now
12
Buy / hold / sell: 6 / 5 / 1
Upside of the analyst’s targets
+63.6%
Average over 12 current targets, to the last price
The market’s answer to the ratings
+4.2%
Day-0 move against SPY in the rating’s direction, average over 13 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 13on TipRanks Oct 14 09:45 | RCUSIWMArcus Biosciences · $2.9B | Reiterated | Buy | $42.00 | +89.9% | −7.5%next day +1.2% | ↗ |
| Oct 7on TipRanks Oct 8 03:15 | RCKTIWMRocket Pharmaceuticals · $259M | Upgrade | Hold | $3.00 → $4.00+33.3% | +83.5% | +2.5%next day +4.2% · 5 days −11.8% | ↗ |
| Oct 5on TipRanks 07:40 | CLDXIWMCelldex · $2.3B | Reiterated | Hold | $38.00 → $28.00−26.3% | +1.7% | +2.3%next day −5.4% · 5 days −10.1% | ↗ |
| Sep 22on TipRanks Sep 23 08:45 | VKTXViking Therapeutics · $3.4B | Reiterated | Hold | $35.00 → $38.00+8.6% | +51.0% | +35.7%next day +2.7% · 5 days −20.9% | ↗ |
| Sep 22on TipRanks Sep 23 07:50 | CLDXIWMCelldex · $2.3B | Reiterated | Hold | $38.00 → $28.00−26.3% | +1.7% | −11.5%next day −6.4% · 5 days −4.4% | ↗ |
| Sep 14on TipRanks 07:35 | OLMAIWMOlema Pharmaceuticals · $601M | Reiterated | Buy | $20.00 → $18.00−10.0% | +173.6% | +1.1%next day −4.5% · 5 days −8.3% | ↗ |
| Aug 31on TipRanks Sep 1 09:05 | PTGXIWMProtagonist Therapeutics · $8.8B | Reiterated | Buy | $186 | +44.5% | +2.7%next day −0.2% · 5 days −1.1% | ↗ |
| Aug 19on TipRanks Aug 20 09:35 | VRDNIWMViridian Therapeutics · $2.2B | Reiterated | Buy | $39.00 → $40.00+2.6% | +110.2% | +3.4%next day −0.4% · 5 days −1.8% | ↗ |
| Aug 12on TipRanks 08:15 | MLYSIWMMineralys Therapeutics, Inc. · $1.9B | Reiterated | Buy | $42.00 → $40.00−4.8% | +97.0% | −1.3%next day −4.2% · 5 days +0.1% | ↗ |
| Aug 11on TipRanks Aug 12 07:15 | BCAXIWMBicara Therapeutics Inc. · $1.2B | Assigned | Hold | $18.00 → $20.00+11.1% | +19.2% | −14.0%next day +3.4% · 5 days +5.3% | ↗ |
| Aug 10on TipRanks Aug 7 06:35 | RCUSIWMArcus Biosciences · $2.9B | Assigned | Buy | $34.00 → $42.00+23.5% | +89.9% | +0.4%next day +0.4% · 5 days +2.6% | ↗ |
| Jul 13on TipRanks Jul 14 08:55 | COAGIWMHemab Therapeutics Holdings, Inc. · $1.5B | Reiterated | Buy | $36.00 → $46.00+27.8% | +53.0% | +4.7%next day +9.3% · 5 days +26.0% | ↗ |
| May 11on TipRanks 07:50 | MLTXMoonLake Immunotherapeutics · $873M | Reiterated | Sell | $11.00 → $12.00+9.1% | +25.7% | +10.2%next day −3.3% · 5 days −12.7% | ↗ |
| Mar 27on TipRanks 07:50 | RCKTIWMRocket Pharmaceuticals · $259M | Reiterated | Sell | $4.69 → $3.00−36.0% | +37.6% | −17.9%next day −8.3% · 5 days −12.1% | ↗ |
| Feb 27on TipRanks 07:55 | ARQTIWMArcutis Biotherapeutics · $3.7B | Reiterated | Hold | $29.00 → $33.00+13.8% | +14.5% | −5.1%next day −8.3% · 5 days −9.0% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗